gbr 12935 has been researched along with Cerebral Ischemia in 1 studies
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toner, CC | 1 |
| Stamford, JA | 1 |
1 other study available for gbr 12935 and Cerebral Ischemia
| Article | Year |
|---|---|
'Real time' measurement of dopamine release in an in vitro model of neostriatal ischaemia.
Topics: Animals; Animals, Newborn; Brain Ischemia; Computer Systems; Dopamine; Dopamine Uptake Inhibitors; E | 1996 |